On May 6, 2024, Greenwave Technology Solutions, Inc. closed the transaction. The company received $112,499,985 in funding pursuant to exemption provided under Regulation D. The transaction included participation from 19 investors.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.19 USD | +0.58% | +10.90% | +11.13% |
May. 10 | Oppenheimer Adjusts Zura Bio Price Target to $21 From $16, Maintains Outperform Rating | MT |
May. 09 | Zura Bio Limited Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.13% | 377M | |
+9.88% | 115B | |
+12.24% | 106B | |
-2.59% | 21.96B | |
-12.63% | 21.87B | |
-5.29% | 19.21B | |
-3.13% | 18.08B | |
-38.57% | 17.71B | |
+7.02% | 14.32B | |
+35.44% | 12.42B |
- Stock Market
- Equities
- ZURA Stock
- News Zura Bio Limited
- Zura Bio Limited announced that it has received $112.4935 million in funding from a group of investors